Across TCGA pan-cancer cohorts, RPL7P47 RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated RPL7P47 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher RPL7P47 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL7P47 expression acts as an unfavorable survival marker, although some lineages such as LUSC and THCA show a favorable association.

KIRP, UVM, and OV are the cancer types where RPL7P47 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Median	All	0.365	0.723	<.001	65	view →
UVM	DFS	Median	III,IV	0.338	0.733	.001	62	view →
OV	OS	Tertile	III,IV	0.242	0.362	.003	48	view →
LUSC	OS	Median	All	0.842	0.679	<.001	41	view →
ACC	DFS	Median	All	0.238	0.765	<.001	40	view →
KICH	OS	Median	III,IV	0.468	1.000	.001	39	view →
LIHC	OS	Tertile	II,III,IV	0.250	0.578	<.001	39	view →
THCA	DFS	Median	All	0.915	0.745	<.001	31	view →
LGG	OS	Tertile	All	0.877	0.720	<.001	31	view →
CESC	OS	Tertile	IV	0.248	0.743	.003	24	view →
BRCA	DFS	Quartile	II,III,IV	0.353	0.643	.002	24	view →
UCEC	DFS	Quartile	All	0.763	0.884	.003	24	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 26 lineages.

Exploration

Same gene, other analysis: RPL7P47 tumor-vs-normal RNA expression · all RPL7P47 data types